Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$294K Buy
2,444
+29
+1% +$3.35K 0.13% 142
2025
Q4
$254K Hold
2,415
0.11% 146
2025
Q3
$203K Sell
2,415
-896
-27% -$73.8K 0.09% 149
2025
Q2
$262K Buy
3,311
+1,063
+47% +$84.5K 0.12% 148
2025
Q1
$202K Sell
2,248
-6,549
-74% -$611K 0.11% 126
2024
Q4
$875K Buy
+8,797
New +$907K 0.49% 51

Other funds holding MRK

Haven Private's MRK Position: Q1 2026 in Review

Haven Private increased its Merck (MRK) stake by 1.2% in Q1 2026, buying an estimated $3.35K and bringing the position to 2,444 shares worth $294K. The position accounts for 0.13% of the portfolio, ranked #142.

Haven Private first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $875K in Q4 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Haven Private held 2,444 shares of Merck worth $294K as of Q1 2026.
  • Haven Private bought 29 Merck shares in Q1 2026, an estimated $3.35K.
  • Merck made up 0.13% of Haven Private's portfolio in Q1 2026, its #142 holding.
  • Haven Private first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • Haven Private's Merck position peaked at $875K in Q4 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Haven Private's 13F filing for Q1 2026, filed 5 May 2026.